Exploration and Validation of the Performance of Hemoglobin A1c in Detecting Diabetes in Community-Dwellers With Hypertension
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Diabetes can complicate hypertension management by increasing the risk of cardiovascular disease (CVD) and all-cause mortality. Studies targeting diabetes detection in hypertensive individuals demonstrating an increased risk of diabetes are lacking. We aimed to assess the performance of hemoglobin A1c (HbA1c) and its cut-off point in detecting diabetes in the abovementioned population. Methods: Data from 4,096 community-dwellers with hypertension but without known diabetes were obtained from the Study on Evaluation of iNnovated Screening tools and determInation of optimal diagnostic cut-off points for type 2 diaBetes in Chinese muLti-Ethnic (SENSIBLE) study; these data were randomly split into exploration (70% of the sample) and internal validation (the remaining 30%) datasets. The optimal HbA1c cut-off point was derived from the exploration dataset and externally validated using another dataset from 2,431 hypertensive individuals. The oral glucose tolerance test was considered the gold-standard for confirming diabetes. Results: The areas under the ROC curves for HbA1c to detect diabetes were 0.842, 0.832, and 0.829 for the exploration, internal validation, and external validation datasets, respectively. An optimal HbA1c cut-off point of 5.8% (40 mmol/mol) yielded a sensitivity of 76.2% and a specificity of 74.5%. Individuals who were not diagnosed as having diabetes by HbA1c at 5.8% (40 mmol/mol) had a lower 10-year CVD risk score than those diagnosed as having diabetes (P=0.01). HbA1c≤5.1% (32 mmol/mol) and ≥6.4% (46 mmol/mol) could indicate the absence and presence of diabetes, respectively. Conclusions: HbA1c could detect diabetes effectively in community-dwellers with hypertension.
Abstract
Background: Diabetes can complicate hypertension management by increasing the risk of cardiovascular disease (CVD) and all-cause mortality. Studies targeting diabetes detection in hypertensive individuals demonstrating an increased risk of diabetes are lacking. We aimed to assess the performance of hemoglobin A1c (HbA1c) and its cut-off point in detecting diabetes in the abovementioned population. Methods: Data from 4,096 community-dwellers with hypertension but without known diabetes were obtained from the Study on Evaluation of iNnovated Screening tools and determInation of optimal diagnostic cut-off points for type 2 diaBetes in Chinese muLti-Ethnic (SENSIBLE) study; these data were randomly split into exploration (70% of the sample) and internal validation (the remaining 30%) datasets. The optimal HbA1c cut-off point was derived from the exploration dataset and externally validated using another dataset from 2,431 hypertensive individuals. The oral glucose tolerance test was considered the gold-standard for confirming diabetes. Results: The areas under the ROC curves for HbA1c to detect diabetes were 0.842, 0.832, and 0.829 for the exploration, internal validation, and external validation datasets, respectively. An optimal HbA1c cut-off point of 5.8% (40 mmol/mol) yielded a sensitivity of 76.2% and a specificity of 74.5%. Individuals who were not diagnosed as having diabetes by HbA1c at 5.8% (40 mmol/mol) had a lower 10-year CVD risk score than those diagnosed as having diabetes (P=0.01). HbA1c≤5.1% (32 mmol/mol) and ≥6.4% (46 mmol/mol) could indicate the absence and presence of diabetes, respectively. Conclusions: HbA1c could detect diabetes effectively in community-dwellers with hypertension.
참고문헌 (30)
- Mills KT, "Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries", Circulation, 134, pp.441~450 (2016)
- Lu J, "Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)", Lancet, 390, pp.2549~2558 (2017)
- Tsimihodimos V, "Hypertension and diabetes mellitus : coprediction and time trajectories", Hypertension, 71, pp.422~428 (2018)
- Li T, "Impact of hypertension with or without diabetes on left ventricular remodeling in rural Chinese population : a cross-sectional study", BMC Cardiovasc Disord, 17, pp.206~ (2017)
- Thomopoulos C, "Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10-Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials", J Hypertens, 35, pp.922~944 (2017)
- Oh JY, "Different impacts of hypertension and diabetes mellitus on all-cause and cardiovascular mortality in community-dwelling older adults: the Rancho Bernardo Study", J Hypertens, 35, pp.55~62 (2017)
- Zafari N, "Impact of hypertension versus diabetes on cardiovascular and all-cause mortality in Iranian older adults : results of 14 years of follow-up", Sci Rep, 7, pp.14220~ (2017)
- Kim MJ, "Hypertension is an independent risk factor for type 2 diabetes : the Korean genome and epidemiology study", Hypertens Res, 38, pp.783~789 (2015)
- Tatsumi Y, "Risk of developing type 2 diabetes according to blood pressure levels and presence or absence of hypertensive treatment: the Saku study", Hypertens Res, 42, pp.105~113 (2019)
- American Diabetes Association, "Diagnosis and classification of diabetes mellitus", Diabetes Care, 33(S1), pp.S62~S69 (2010)
- Bennett CM, "HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review", Diabet Med, 24, pp.333~343 (2007)
- Bertran EA, "Diagnostic performance of HbA1c for diabetes in Arab vs. European populations: a systematic review and meta-analysis", Diabet Med, 34, pp.156~166 (2017)
- Jose-Maria Maesa,, "Screening for Gestational Diabetes Mellitus by Measuring Glycated Hemoglobin Can Reduce the Use of the Glucose Challenge Test", Annals of Laboratory Medicine, 39(6), pp.524~529 (2019), 대한진단검사의학회[DOI]
- Ehehalt S, "Diabetes screening in overweight and obese children and adolescents : choosing the right test", Eur J Pediatr, 176, pp.89~97 (2017)
- Li W, "Non-lab and semi-lab algorithms for screening undiagnosed diabetes : a cross-sectional study", EBioMedicine, 35, pp.307~316 (2018)
- Bossuyt PM, "STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies", BMJ, 351, pp.h5527~ (2015)
- Cas Weykamp, "HbA1c: A Review of Analytical and Clinical Aspects", Annals of Laboratory Medicine, 33(6), pp.393~400 (2013), 대한진단검사의학회
- Gabir MM, "The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes", Diabetes Care, 23, pp.1108~1112 (2000)
- D’Agostino RB Sr, "General cardiovascular risk profile for use in primary care : the Framingham Heart Study", Circulation, 117, pp.743~753 (2008)
- Safari S, "Evidence based emergency medicine; part 5 receiver operating curve and area under the curve", Emerg (Tehran), 4, pp.111~113 (2016)
- Altman DG, "Interaction revisited : the difference between two estimates", BMJ, 326, pp.219~ (2003)
- Lu ZX, "A1C for screening and diagnosis of type 2 diabetes in routine clinical practice", Diabetes Care, 33, pp.817~819 (2010)
- Li G, "Evaluation of ADA HbA1c criteria in the diagnosis of pre-diabetes and diabetes in a population of Chinese adolescents and young adults at high risk for diabetes: a cross-sectional study", BMJ Open, 8, pp.e020665~ (2018)
- Hoyer A, "Utility of HbA1c and fasting plasma glucose for screening of Type 2 diabetes: a meta-analysis of full ROC curves", Diabet Med, 35, pp.317~322 (2018)
- Franco LJ, "Performance of glycated haemoglobin (HbA1c) as a screening test for diabetes and impaired glucose tolerance (IGT) in a high risk population–the Brazilian Xavante Indians", Diabetes Res Clin Pract, 106, pp.337~342 (2014)
- Peter A, "Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk", Exp Clin Endocrinol Diabetes, 119, pp.234~237 (2011)
- Lee H, "Optimal hemoglobin A1C cutoff value for diagnosing type 2 diabetes mellitus in Korean adults", Diabetes Res Clin Pract, 99, pp.231~236 (2013)
- Smith AD, "Physical activity and incident type 2 diabetes mellitus : a systematic review and dose–response meta-analysis of prospective cohort studies", Diabetologia, 59, pp.2527~2545 (2016)
- Casula M, "Statin use and risk of new-onset diabetes: a meta-analysis of observational studies", Nutr Metab Cardiovasc Dis, 27, pp.396~406 (2017)
- Di Bonito P, "A new index to simplify the screening of hypertension in overweight or obese youth", Nutr Metab Cardiovasc Dis, 27, pp.830~835 (2017)